KMS Medisurgi
KMS Medisurgi
HealthcareKey Fundamentals
SMEMedical EquipmentHealthcareTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
3- Stock is trading at 5.27 times its book value
- The company has delivered a poor sales growth of 10.2% over past five years.
- Company has a low return on equity of 5.02% over last 3 years.
Growth Rate
Quarterly Results
| Particulars | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.2 | 2.76 | 4.75 | 5.5 | 4.82 | 5.68 | 5.35 | 7.15 | 6.73 | 7.81 | 6.12 | 6.62 | 5.59 |
| Expenses | 4.83 | 2.5 | 4.51 | 5.2 | 4.6 | 5.34 | 4.72 | 6.24 | 6.85 | 7.59 | 5.4 | 6.11 | 5.2 |
| Operating Profit | 0.37 | 0.26 | 0.24 | 0.3 | 0.22 | 0.34 | 0.63 | 0.91 | -0.12 | 0.22 | 0.72 | 0.51 | 0.39 |
| OPM % | 7.12% | 9.42% | 5.05% | 5.45% | 4.56% | 5.99% | 11.78% | 12.73% | -1.78% | 2.82% | 11.76% | 7.7% | 6.98% |
| Other Income | 0 | 0 | 0.1 | 0 | 0.05 | 0 | 0.01 | 0.06 | 0.03 | 0.02 | 0.01 | 0.04 | -0.03 |
| Interest | 0.05 | 0.01 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.01 | 0.08 | 0.06 | 0.05 |
| Depreciation | 0.2 | 0.16 | 0.18 | 0.14 | 0.15 | 0.12 | 0.19 | 0.12 | 0.13 | 0.12 | 0.14 | 0.19 | 0.28 |
| PBT | 0.12 | 0.09 | 0.14 | 0.16 | 0.12 | 0.22 | 0.45 | 0.85 | -0.24 | 0.11 | 0.51 | 0.3 | 0.03 |
| Tax % | 58.33% | 0% | 57.14% | 25% | 25% | -18.18% | 28.89% | 28.24% | -37.5% | 27.27% | 27.45% | 20% | 66.67% |
| Net Profit | 0.05 | 0.09 | 0.07 | 0.12 | 0.09 | 0.26 | 0.31 | 0.6 | -0.15 | 0.08 | 0.36 | 0.23 | 0.01 |
| EPS in Rs | 0.15 | 0.27 | 0.21 | 0.36 | 0.27 | 0.79 | 0.94 | 1.82 | -0.45 | 0.24 | 1.09 | 0.7 | 0.03 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.89 | 8.41 | 7.9 | 7.32 | 9.86 | 10.34 | 7.51 | 10.32 | 11.03 | 13.88 | 13.94 | 12.21 |
| Expenses | 8.17 | 7.59 | 6.95 | 6.85 | 9.56 | 9.68 | 7.01 | 9.79 | 10.07 | 13.03 | 12.99 | 11.31 |
| Operating Profit | 0.72 | 0.82 | 0.95 | 0.47 | 0.3 | 0.66 | 0.5 | 0.53 | 0.96 | 0.85 | 0.95 | 0.9 |
| OPM % | 8.1% | 9.75% | 12.03% | 6.42% | 3.04% | 6.38% | 6.66% | 5.14% | 8.7% | 6.12% | 6.81% | 7.37% |
| Other Income | 0.04 | 0.06 | 0.17 | 0.35 | 0.42 | 0 | 0.1 | 0.05 | 0.02 | 0.03 | 0.03 | 0.01 |
| Interest | 0.27 | 0.24 | 0.27 | 0.19 | 0.09 | 0.07 | 0.03 | 0 | 0 | 0.02 | 0.1 | 0.11 |
| Depreciation | 0.41 | 0.34 | 0.49 | 0.45 | 0.43 | 0.41 | 0.33 | 0.29 | 0.32 | 0.25 | 0.27 | 0.47 |
| PBT | 0.08 | 0.3 | 0.36 | 0.18 | 0.2 | 0.18 | 0.24 | 0.29 | 0.66 | 0.61 | 0.61 | 0.33 |
| Tax % | 50% | 53.33% | 38.89% | 50% | 40% | 38.89% | 45.83% | 24.14% | 13.64% | 24.59% | 27.87% | 27.27% |
| Net Profit | 0.03 | 0.14 | 0.21 | 0.1 | 0.12 | 0.11 | 0.12 | 0.22 | 0.57 | 0.45 | 0.44 | 0.25 |
| EPS in Rs | 0.6 | 1.17 | 0.88 | 0.3 | 0.36 | 0.33 | 0.36 | 0.67 | 1.73 | 1.36 | 1.33 | 0.76 |
| Div. Payout % | 0% | 25.71% | 5.71% | 16.5% | 13.75% | 15% | 13.75% | 7.5% | 2.89% | 3.67% | 3.75% | 0% |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.5 | 1.2 | 2.4 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 |
| Reserves | 0.64 | 2.13 | 1.12 | 2.85 | 2.95 | 3.05 | 3.15 | 3.37 | 3.93 | 4.36 | 4.79 | 5.01 |
| Borrowings | 2.85 | 2.13 | 2.73 | 1.91 | 1.13 | 1.11 | 1.03 | 0.99 | 0.99 | 0.54 | 0.91 | 0.77 |
| Other Liabilities | 3.21 | 2.6 | 2.36 | 2.14 | 3.15 | 1.64 | 1.86 | 2.17 | 1.51 | 2.65 | 1.34 | 1.47 |
| Total Liabilities | 7.2 | 8.06 | 8.61 | 10.2 | 10.53 | 9.1 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 10.55 |
| Fixed Assets | 2.25 | 1.98 | 2.69 | 2.25 | 2.2 | 1.81 | 1.65 | 1.48 | 1.82 | 1.65 | 1.68 | 2.93 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 4.95 | 6.08 | 5.92 | 7.95 | 8.33 | 7.29 | 7.69 | 8.35 | 7.91 | 9.2 | 8.66 | 7.62 |
| Total Assets | 7.2 | 8.06 | 8.61 | 10.2 | 10.53 | 9.1 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 10.55 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1.35 | -0.24 | 0.9 | -1.57 | 0.75 | -0.84 | 0.53 | -0.07 | 0.46 | 1.21 | 0.74 | 1.51 |
| Investing | 0.05 | -0.03 | -1.1 | 0.11 | -0.31 | 0.01 | -0.1 | -0.12 | -0.66 | -0.51 | -0.96 | -0.61 |
| Financing | -1.41 | 1.13 | 1.75 | 1.57 | -0.81 | -0.06 | -0.11 | -0.02 | -0.01 | -0.47 | 0.27 | -0.26 |
| Net Cash Flow | -0.01 | 0.86 | 1.56 | 0.1 | -0.37 | -0.88 | 0.32 | -0.21 | -0.21 | 0.23 | 0.05 | 0.64 |
| Free Cash Flow | 1.4 | -0.31 | -0.29 | -1.58 | 0.36 | -0.86 | 0.36 | -0.19 | -0.2 | 1.09 | 0.44 | -0.21 |
| CFO/OP | 188 | -18 | 106 | -309 | 250 | -129 | 108 | 0 | 59 | 173 | 96 | 177 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 128 | 163 | 186 | 233 | 187 | 194 | 305 | 231 | 216 | 152 | 111 | 96.26 |
| Inventory Days | 50.02 | 17.78 | 6.24 | 85.34 | 82.27 | 62.14 | — | 45.45 | 42.45 | 70.96 | 87.18 | 105 |
| Days Payable | 156 | 141 | 140 | 135 | 134 | 70.42 | — | 100 | 58.6 | 85.22 | 41.86 | 52.14 |
| Cash Conversion Cycle | 22.61 | 39.94 | 52.21 | 184 | 135 | 186 | 305 | 176 | 200 | 138 | 156 | 149 |
| Working Capital Days | 21.76 | 30.81 | 9.24 | 158 | 148 | 189 | 253 | 201 | 200 | 154 | 144 | 142 |
| ROCE % | 7.7% | 11.43% | 10.76% | 5.17% | 3.76% | 3.37% | 3.61% | 3.83% | 8.31% | 8.4% | 8.26% | 4.87% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view KMS Medisurgi insights
60 extracted metrics + investor summaries across FY15–FY26.
Documents
Frequently Asked Questions about KMS Medisurgi
What does KMS Medisurgi Ltd do?
Where is KMS Medisurgi Ltd (540468) listed?
Which sector does KMS Medisurgi Ltd belong to?
What is the market capitalisation of KMS Medisurgi Ltd?
What is the PE ratio of KMS Medisurgi Ltd?
What is the 52-week high and low of KMS Medisurgi Ltd?
Does KMS Medisurgi Ltd pay dividends?
What is the Return on Equity (ROE) of KMS Medisurgi Ltd?
Company Information
Incorporated in 2016, KMS Medisurgi Ltd operates in the manufacturing of Surgical Equipment.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540468.md for KMS Medisurgi Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.